vs
费森尤斯医疗（FMS）与Progyny, Inc.（PGNY）财务数据对比。点击上方公司名可切换其他公司
费森尤斯医疗的季度营收约是Progyny, Inc.的17.2倍（$5.5B vs $318.4M）。费森尤斯医疗净利率更高（7.9% vs 3.9%，领先4.0%）。Progyny, Inc.同比增速更快（6.7% vs -0.3%）
费森尤斯医疗是德国知名医疗保健企业，核心业务为肾脏透析服务，在全球运营4171家门诊透析中心，服务约34.54万名患者。公司主要为终末期肾病患者提供治疗服务，该类患者需终身每周接受3次透析治疗以维持生命。
Progyny, Inc.是总部位于美国的领先生育与家庭构建福利服务商，主要与企业雇主合作，提供试管婴儿、生育力保存、收养协助、代孕支持等综合生育相关福利方案，覆盖多个行业的雇员群体。
FMS vs PGNY — 直观对比
营收规模更大
FMS
是对方的17.2倍
$318.4M
营收增速更快
PGNY
高出7.0%
-0.3%
净利率更高
FMS
高出4.0%
3.9%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $5.5B | $318.4M |
| 净利润 | $434.2M | $12.5M |
| 毛利率 | 27.4% | 24.1% |
| 营业利润率 | 11.7% | 4.8% |
| 净利率 | 7.9% | 3.9% |
| 营收同比 | -0.3% | 6.7% |
| 净利润同比 | 240.4% | 18.5% |
| 每股收益（稀释后） | — | $0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FMSPGNY
| Q4 25 | $5.5B | $318.4M | ||
| Q3 25 | — | $313.3M | ||
| Q2 25 | — | $332.9M | ||
| Q1 25 | — | $324.0M | ||
| Q4 24 | $5.5B | $298.4M | ||
| Q3 24 | — | $286.6M | ||
| Q2 24 | — | $304.1M | ||
| Q1 24 | — | $278.1M |
净利润FMSPGNY
| Q4 25 | $434.2M | $12.5M | ||
| Q3 25 | — | $13.9M | ||
| Q2 25 | — | $17.1M | ||
| Q1 25 | — | $15.1M | ||
| Q4 24 | $127.6M | $10.5M | ||
| Q3 24 | — | $10.4M | ||
| Q2 24 | — | $16.5M | ||
| Q1 24 | — | $16.9M |
毛利率FMSPGNY
| Q4 25 | 27.4% | 24.1% | ||
| Q3 25 | — | 23.2% | ||
| Q2 25 | — | 23.7% | ||
| Q1 25 | — | 23.4% | ||
| Q4 24 | 25.0% | 21.3% | ||
| Q3 24 | — | 20.7% | ||
| Q2 24 | — | 22.5% | ||
| Q1 24 | — | 22.4% |
营业利润率FMSPGNY
| Q4 25 | 11.7% | 4.8% | ||
| Q3 25 | — | 6.9% | ||
| Q2 25 | — | 7.3% | ||
| Q1 25 | — | 7.5% | ||
| Q4 24 | 5.1% | 5.3% | ||
| Q3 24 | — | 4.3% | ||
| Q2 24 | — | 6.8% | ||
| Q1 24 | — | 6.7% |
净利率FMSPGNY
| Q4 25 | 7.9% | 3.9% | ||
| Q3 25 | — | 4.4% | ||
| Q2 25 | — | 5.1% | ||
| Q1 25 | — | 4.6% | ||
| Q4 24 | 2.3% | 3.5% | ||
| Q3 24 | — | 3.6% | ||
| Q2 24 | — | 5.4% | ||
| Q1 24 | — | 6.1% |
每股收益（稀释后）FMSPGNY
| Q4 25 | — | $0.14 | ||
| Q3 25 | — | $0.15 | ||
| Q2 25 | — | $0.19 | ||
| Q1 25 | — | $0.17 | ||
| Q4 24 | — | $0.12 | ||
| Q3 24 | — | $0.11 | ||
| Q2 24 | — | $0.17 | ||
| Q1 24 | — | $0.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.7B | $112.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $15.4B | $516.0M |
| 总资产 | $33.5B | $742.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FMSPGNY
| Q4 25 | $1.7B | $112.2M | ||
| Q3 25 | — | $134.0M | ||
| Q2 25 | — | $132.5M | ||
| Q1 25 | — | $109.2M | ||
| Q4 24 | $1.3B | $162.3M | ||
| Q3 24 | — | $91.5M | ||
| Q2 24 | — | $95.0M | ||
| Q1 24 | — | $115.0M |
股东权益FMSPGNY
| Q4 25 | $15.4B | $516.0M | ||
| Q3 25 | — | $560.0M | ||
| Q2 25 | — | $515.0M | ||
| Q1 25 | — | $467.2M | ||
| Q4 24 | $17.0B | $422.1M | ||
| Q3 24 | — | $434.9M | ||
| Q2 24 | — | $456.2M | ||
| Q1 24 | — | $571.6M |
总资产FMSPGNY
| Q4 25 | $33.5B | $742.4M | ||
| Q3 25 | — | $795.2M | ||
| Q2 25 | — | $761.0M | ||
| Q1 25 | — | $730.3M | ||
| Q4 24 | $36.3B | $607.1M | ||
| Q3 24 | — | $660.0M | ||
| Q2 24 | — | $698.6M | ||
| Q1 24 | — | $794.3M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.9B | $54.2M |
| 自由现金流经营现金流 - 资本支出 | — | $48.6M |
| 自由现金流率自由现金流/营收 | — | 15.3% |
| 资本支出强度资本支出/营收 | — | 1.8% |
| 现金转化率经营现金流/净利润 | 6.67× | 4.34× |
| 过去12个月自由现金流最近4个季度 | — | $191.8M |
8季度趋势，按日历期对齐
经营现金流FMSPGNY
| Q4 25 | $2.9B | $54.2M | ||
| Q3 25 | — | $50.7M | ||
| Q2 25 | — | $55.5M | ||
| Q1 25 | — | $49.8M | ||
| Q4 24 | $2.6B | $52.2M | ||
| Q3 24 | — | $44.5M | ||
| Q2 24 | — | $56.7M | ||
| Q1 24 | — | $25.7M |
自由现金流FMSPGNY
| Q4 25 | — | $48.6M | ||
| Q3 25 | — | $46.0M | ||
| Q2 25 | — | $50.2M | ||
| Q1 25 | — | $47.0M | ||
| Q4 24 | — | $50.3M | ||
| Q3 24 | — | $42.7M | ||
| Q2 24 | — | $55.8M | ||
| Q1 24 | — | $24.9M |
自由现金流率FMSPGNY
| Q4 25 | — | 15.3% | ||
| Q3 25 | — | 14.7% | ||
| Q2 25 | — | 15.1% | ||
| Q1 25 | — | 14.5% | ||
| Q4 24 | — | 16.8% | ||
| Q3 24 | — | 14.9% | ||
| Q2 24 | — | 18.4% | ||
| Q1 24 | — | 8.9% |
资本支出强度FMSPGNY
| Q4 25 | — | 1.8% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 1.6% | ||
| Q1 25 | — | 0.9% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | — | 0.3% |
现金转化率FMSPGNY
| Q4 25 | 6.67× | 4.34× | ||
| Q3 25 | — | 3.65× | ||
| Q2 25 | — | 3.24× | ||
| Q1 25 | — | 3.31× | ||
| Q4 24 | 20.20× | 4.95× | ||
| Q3 24 | — | 4.27× | ||
| Q2 24 | — | 3.44× | ||
| Q1 24 | — | 1.52× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FMS
暂无分部数据
PGNY
| Fertility Benefit Services | $208.6M | 66% |
| Pharmacy Benefit Services | $109.8M | 34% |
